Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade

Am J Cancer Res. 2022 Jun 15;12(6):2891-2892. eCollection 2022.

¹ Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
² Department of Clinical Laboratory, The Children's Hospital, Zhejiang University School of Medicine Hangzhou 310052, Zhejiang, China.
³ Department of Orthopedics, Third Affiliated Hospital of Wenzhou Medical University Wenzhou 325200, Zhejiang, China.
⁴ Department of Pathology, First Affiliated Hospital of Wenzhou Medical University Wenzhou 325035, Zhejiang, China.

Abstract

[This corrects the article on p. 688 in vol. 10, PMID: 32195036.].